CONTINUUS Pharmaceuticals

CONTINUUS Pharmaceuticals specializes in Integrated Continuous Manufacturing (ICM)—a transformative approach that replaces traditional batch processes with end-to-end continuous flows for active pharmaceutical ingredients (APIs) and final dosage forms.

Core Capabilities

Drug Substance / API Development & Manufacturing:

• Flow Chemistry reactions
• Polish filtration and continuous crystallization
• Solvent recovery and continuous filtration
• Continuous drying

Drug Product Development & Manufacturing:

• Continuous formulation and drug product development
• Extrusion, injection molding, and coating operations

Supporting Technologies:

• Advanced process analytical technology (PAT)
• Proprietary control systems
• Process modeling and optimization

Key Differentiators

Modular Architecture: Each unit operation can operate independently or integrate into a complete ICM line, enabling flexible adoption and stepwise implementation.

Performance Metrics (case study data):

• 30–50% reduction in cost of goods sold (COGS)
• Finished, coated tablets in <48 hours (vs. months in batch)
• 80% reduction in number of unit operations
• 60% reduction in solvent use
• 50–60% reduction in energy consumption
• 90% reduction in plant footprint

Multi-Product & Future-Proof: Modules can be swapped or reconfigured to accommodate new products, processes, or throughput needs, and extended or upgraded as demand grows or regulations shift.